Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
Statistical Methods in Medical Research|June 28, 2011
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discoveryG Niklas Norén, Johan Hopstadius, Andrew BateDrug Safety|April 3, 2012
Defining 'surveillance' in drug safetyJeffrey K Aronson, Manfred Hauben, Andrew BateJournal of Hepatology|June 24, 2008
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis CXiaowen Su, Leland J Yee, KyungAh Im, et al.Drug Safety|July 19, 2008
Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactionsStaffan Hägg, Andrew Bate, Malin Stahl, et al.Statistical Methods in Medical Research|September 1, 2011
Disproportionality methods for pharmacovigilance in longitudinal observational databasesIvan Zorych, David Madigan, Patrick Ryan, et al.Pharmaceutical Statistics|April 16, 2024
Tree-temporal scan statistics for safety signal detection in vaccine clinical trialsFrançois Haguinet, Fabian Tibaldi, Christophe Dessart, et al.Drug Safety|June 20, 2002
A data mining approach for signal detection and analysisAndrew Bate, Marie Lindquist, I Ralph Edwards, et al.Drug Safety|January 13, 2018
Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records DatabaseXiaofeng Zhou, Ian J Douglas, Rongjun Shen, et al.Pharmaceutical Statistics|October 27, 2018
Lessons from meta-analyses of randomized clinical trials for analysis of distributed networks of observational databasesAndrew Bate, Christy Chuang-Stein, Andrew Roddam, et al.British Journal of Clinical Pharmacology|September 11, 2009
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interactionJohanna Strandell, Andrew Bate, Staffan Hägg, et al.Pageof 12